Although he was overwhelmingly approved by the Senate, the new chief of the Food and Drug Administration, Dr. Robert Califf, clearly heard the message from the handful of senators who wanted to block his confirmation based on his association with an agency that they say has been complicit in America's opioid epidemic.
In remarks Tuesday, Califf promised to work hard to make painkillers less addictive and to put warning labels on drugs. Recently, some opioid medications have been designed in ways to make them harder to snort or inject.
Califf said "the promise that we are on a path toward products that are effective in preventing abuse both by patients and non-patients is real," according to the AP.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
